SCHEMBL25926358

SCHEMBL25926358

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4c3oc3ccc(-c5cccc6c5oc5ccc(-n7c8ccccc8c8ccccc87)cc56)cc34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.41
PRKDC P78527 3/20 0.34
GGPS1 O95749 1/20 0.34
PTPRF P10586 6/20 0.34
PTPN2 P17706 6/20 0.34
PTPN1 P18031 6/20 0.34
MAPT P10636 3/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PIK3CG P48736 1/20 0.34
ALDH1A1 P00352 2/20 0.33
TSHR P16473 2/20 0.33
KDM4E B2RXH2 2/20 0.33
PIM1 P11309 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25926301 0.97 ALOX5 (0.38) ALOX5PRKDCGGPS1PTPRFPTPN2
SCHEMBL25926640 0.97 ALOX5 (0.42) ALOX5PRKDCGGPS1PTPRFPTPN2
SCHEMBL25926592 0.97 ALOX5 (0.42) ALOX5PRKDCGGPS1PTPRFPTPN2
SCHEMBL18562285 0.96 ALOX5 (0.43) ALOX5PRKDCGGPS1PTPRFPTPN2
SCHEMBL18562282 0.96 ALOX5 (0.43) ALOX5PRKDCGGPS1PTPRFPTPN2
SCHEMBL25458450 0.96 ALOX5 (0.38) ALOX5PRKDCGGPS1PTPRFPTPN2
SCHEMBL25926380 0.96 ALOX5 (0.36) ALOX5PRKDCPTPRFPTPN2PTPN1
SCHEMBL24215900 0.96 ALOX5 (0.38) ALOX5PRKDCPTPRFPTPN2PTPN1
SCHEMBL17231985 0.96 ALOX5 (0.36) ALOX5PRKDCGGPS1PTPRFPTPN2
SCHEMBL25926321 0.95 ALOX5 (0.41) ALOX5PRKDCGGPS1PTPRFPTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 ALOX5 959/4885PRKDC 3471/4885GGPS1 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.